Alecensa : What do I need to know?
When a lung cancer called non-small-cell lung cancer (NSCLC) has advanced in adults and the disease has either not been treated in the past or has been treated in the past with a cancer drug called Xalkori (crizotinib), a medicine called Alecensa is used to treat the disease. Alecensa is a cancer medicine.
Alecensa is prescribed to people who have been diagnosed with non-small cell lung cancer, which is a subtype of lung cancer.
Alecensa is able to inhibit the ALK protein from carrying out its function. There is a possibility that alecensa will halt or significantly reduce the progression of your cancer. It will facilitate the reduction of the size of your cancer.